Search clinical trials for: plasma glucagon-like peptide-1 levels
Total 351 results
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Ireland, Belgium, Romania, Germany, Russian... and more
-
University Medical Center GroningenNovo Nordisk A/SCompletedObesity | AlbuminuriaNetherlands, Germany, Spain, Canada
-
Sabyasachi SenCompleted
-
Viral N. ShahJuvenile Diabetes Research FoundationActive, not recruitingObesity | Type 1 DiabetesUnited States
-
Novo Nordisk A/SRecruitingObesity | OverweightChina, Taiwan
-
Novo Nordisk A/SRecruitingObesityBelgium, United Kingdom, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico, Denmark
-
National Institute of Allergy and Infectious Diseases...The University of Texas Health Science Center, HoustonCompletedHIV Infections | Non-Alcoholic Fatty Liver DiseaseUnited States, Brazil
-
DarierUnknown
-
Massachusetts General HospitalJoslin Diabetes CenterCompleted
-
Rigshospitalet, DenmarkDepartment of Cardiovascular and Renal Research, University of Southern DenmarkCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Bulgaria, Czechia, Hungary, Poland, Russian Federation
-
Novo Nordisk A/SNot yet recruitingObesityUnited Kingdom, Germany, Canada, United States, France
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
University of Banja LukaCompletedPsoriasis Vulgaris | Diabetes Type 2Bosnia and Herzegovina
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer´s DiseaseCanada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Vanderbilt University Medical CenterNashville VA Medical CenterActive, not recruitingChronic Kidney DiseasesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Denmark, Sweden, Austria
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, South Africa, China, Slovakia
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Thailand, Poland, Czechia, Malaysia, Serbia
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Serbia, Italy, China, Poland, Hungary, Saudi Arabia
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedObesityUnited States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, China, India, United States, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
University Hospital, Gentofte, CopenhagenCompletedObesity | Type 2 Diabetes | AdiposityDenmark
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.Completed
-
Mayo ClinicAstellas Pharma US, Inc.; University of Nebraska; Lantheus Medical ImagingCompletedCoronary Artery Disease | Diabetes Mellitus Type 2United States
-
University Hospital, Gentofte, CopenhagenMerck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Germany
-
University of CopenhagenRigshospitalet, Denmark; Bispebjerg HospitalCompletedObesity | Type 1 Diabetes | Non-Alcoholic Fatty Liver Disease | Glucagon ResistanceDenmark
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Type 2 Diabetes MellitusUnited States
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
Second Xiangya Hospital of Central South UniversityGuangdong Provincial People's Hospital; The First Affiliated Hospital of Henan... and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Overweight or ObesityChina
-
Xeris PharmaceuticalsCompleted
-
Second Xiangya Hospital of Central South UniversityRecruitingFibrosis | Scleroderma, Systemic | SemaglutideChina
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Shenzhen Institute of Advanced Technology, Chinese...Recruiting
-
Veru Inc.RecruitingObesity | Muscle LossUnited States